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Identity 
Other names: human retinoblastoma suspectibility 
gene 
HGNC (Hugo) : RB1 
Location : 13q14 
DNA/RNA 
Description 
27 exons spanning 180 kb. 
 
 c-RB1 at 13q14 in normal cells: PAC 825K22 (top) and PAC 
971H14 (bottom) - Courtesy Mariano Rocchi. 
Transcription 




928 aa nuclear phosphoprotein; 110 kDa; pRB is 
phosphorylated by members of the cyclin-dependent 
kinase (cdk) system prior to the entry into S-phase; 
hypophosphorylated pRB binds to members of the E2F 
family of transcription factors; binding to E2F is 







Cell cycle regulation, differentiation. 
Homology 
pRB, p107, and p130 constitute a small family of 
nuclear proteins with significant sequence similarity in 
two discontinuous areas (pockets domains); conditional 
on the phosphorylation status, these pocket proteins ca  
bind transforming proteins of DNA tumor viruses as 
well as nuclear proteins. 
Mutations 
Germinal 
Germline mutations in the RB1 gene are causative for 
hereditary predisposition to retinoblastoma; the 
spectrum of predisposing mutations includes large 
deletions (about 20%), single base substitutions (about 
50%) and small length mutations (about 30%); most 
mutations are associated with almost complete 
penetrance: some rare alleles show incomplete 
penetrace and reduced expressivity (low penetrance 
retinoblastoma). 
Somatic 
In retinoblastomas, both RB1 alleles are mutated; in 
addtion to the mutational spectrum of germinal 
mutations, retinoblastomas can show loss of 
heterozygosity and hypermethylation at the CpG-island 
associated with the 5Œ-end of the RB1 gene. 
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Hereditary predisposition to retinoblastoma formation 
in carrieres of a germinal mutation. Somatic 




Carriers of a germinal RB1gene mutation are 
predisposed to soft tissue sarcomas and osteogenic 
sarcomas. Somatic inactivation of both RB1 alleles 
observed in some sarcomas 
Various cancers 
Disease 
RB1 gene mutations have been observed in several 
tumor entities. In lung cancer there is a notable high 
frequency of RB1 gene mutations although no 
increased incidence of these tumors has been observed 
in carriers of a germinal RB1 gene mutation. 
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